VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

44 hedge funds and large institutions have $19.6M invested in Viracta Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 13 closing their positions.

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
8
Reduced
10
Closed
13
Calls
$47K
Puts
$10K
Net Calls
+$37K
Net Calls Change
-$65K

Top Buyers

1
MB
1
MPM BioImpact
Massachusetts
$949K
2
CC
2
Caxton Corporation
New Jersey
$2.75M
3
SB
3
Samsara BioCapital
California
$2.01M
4
APM
4
Avidity Partners Management
Texas
$473K
5
NCM
5
Nantahala Capital Management
Connecticut
$2.96M

Top Sellers

1
RI
1
RTW Investments
New York
$0
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
SI
3
Sofinnova Investments
California
$0
4
DCM
4
DAFNA Capital Management
California
$0
5
ACP
5
Acuta Capital Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
– – -1,556 Closed
PA
52
Parallel Advisors
California
$0 332 -27 -8%
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
SPIA
54
Steward Partners Investment Advisory
New York
$0 33 – –
S
55
SignatureFD
Georgia
$0 55 – –
Wolverine Trading
56
Wolverine Trading
Illinois
– – – –
TWA
57
TCI Wealth Advisors
Arizona
$0 23 – –
AG
58
Advisor Group
Arizona
$0 183 – –
PFGIA
59
Patriot Financial Group Insurance Agency
Massachusetts
$0 249 – –
1 2
3